Status:
COMPLETED
The Effect of Hypnosis on Blood Concentrations of Endocannabinoids
Lead Sponsor:
Université de Sherbrooke
Conditions:
Hypnosis
Endocannabinoids
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Introduction: Many interventions such as hypnosis, mindfulness meditation, conditioned pain modulation and placebos have been shown to effectively reduce pain both in the laboratory and in clinical se...
Eligibility Criteria
Inclusion
- Being an healthy adult aged 18-45 years old with no prior experience of hypnosis.
Exclusion
- Having difficulty understanding french language
- Having a vulnerability to dissociative or psychotic episodes
- Having a diagnosed medical condition or diagnosis of chronic pain leading to kidney, liver, dermatological, respiratory, hematological, immunological, cardiovascular, inflammatory, rheumatologic, endocrine, metabolic, neurological or psychiatric pathologies
- Being pregnant or breast-feeding
- Having a body mass index over 40
- Using medication, recreational drugs or other agents that affect the central nervous system or the perception of pain (e.g., analgesics, opioids, antiepileptics, muscle relaxers)
Key Trial Info
Start Date :
November 14 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03407937
Start Date
November 14 2017
End Date
September 1 2018
Last Update
October 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRCHUS: Centre de recherche du centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada, J1H5N4